Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Anglo American Leads Business Community With Pledge to the UK Matching Fund for Immunisation to Support GAVI


News provided by

Anglo American Plc

09 Jun, 2011, 11:02 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, June 9, 2011 /PRNewswire/ --

Anglo American today pledged $3 million to the UK Government led matching initiative for the Global Alliance for Vaccines and Immunisations (GAVI) - a public/private partnership dramatically increasing access to immunisation in the world's poorest countries.

Anglo American is the first UK plc to participate in the GAVI Matching Fund for Immunisation, launched today by the International Development Secretary, Andrew Mitchell and the Chancellor, George Osborne. The UK Government has also committed to matching funds raised from Anglo American employees and suppliers as part of the initiative.

Cynthia Carroll, Chief Executive of Anglo American, commented:

"Anglo American is delighted to announce its commitment of $1 million a year for three years to the UK Government led Matching Fund initiative for GAVI. We hope that our action will encourage a similar level of support for GAVI from other large companies in the UK and around the world. We are also actively encouraging our employees and suppliers to participate in this important initiative.

"With approximately 95% of our operations in developing countries, Anglo American has a deep appreciation of the vital role health plays in ensuring human development and promoting economic growth."

Anglo American strongly believes that a collective and innovative response is required from business in order to have a meaningful impact on improving access to healthcare in developing countries. At the G20 Business Summit in Seoul in November 2010, Anglo American announced a $3 million pledge over three years to the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) and called on businesses around the world to do the same.

"The scale of the burden of disease in developing countries demands a coordinated response between governments, the private sector and civil society. Anglo American is committed to supporting innovative health financing partnerships like GAVI and the Global Fund, which are tackling these significant healthcare challenges with extraordinary success," Cynthia Carroll said.

Dr Brian Brink, Chief Medical Officer, Anglo American, based in South Africa, commented:

"Since 2000, GAVI funded vaccines have immunised 288 million children and prevented more than 5 million deaths. Global Fund sponsored programs have saved 6.5 million lives and provided access to treatment for more than 3 million AIDS patients and 7.7 million Tuberculosis patients. Malaria may be eliminated as a public health problem by 2015, largely as a result of Global Fund investments. By supporting both these institutions, Anglo American is a leading business contributor to improving health in countries with the greatest need.

"Despite these remarkable achievements, funding shortfalls remain. We urge the private sector to recognise the importance of investing in health in developing countries; there are significant long-term business benefits in terms of economic growth and development. For Anglo American, improving access to healthcare is an important part of our sustainable development programme, which aims to make a real and lasting difference in the communities where our mines operate."

Notes to editors

Further information about Anglo American's health programmes

- In 2002, Anglo American was the first major employer to begin offering free antiretroviral treatment to all its employees and, in December 2008, Anglo American extended this benefit to employees' direct dependants. This decision was based largely on the understanding that HIV/AIDS cannot be effectively managed when only one family member receives care for a disease that affects the whole family.

- Anglo American's world-leading HIV/AIDS response, providing the largest free HIV and AIDS workplace and voluntary counselling and testing (VCT) programme, has been held up as best practice by the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria.

- Anglo American's 2009 international employee HIV/AIDS campaign detailed the company's response in the areas of eliminating the stigma and discrimination related to the disease. The programme also focuses on preventing new infections, the provision of care and confidential support for employees and their dependants infected with and affected by HIV/AIDS, and managing and mitigating the impact of HIV/AIDS on operations. In so doing, Anglo American is making a positive contribution towards minimising the social, economic and developmental consequences of the epidemic.

- Workplace programmes are in place at all Group operations and business units, with activity particularly focused in southern Africa, where HIV prevalence figures are estimated at 18% of the region's workforce.

- In 2011, Anglo American co-sponsored the Frontline Heroes in Health award with Virgin Unite which was presented at GBC Health's 10th Anniversary Conference and Awards. The award recognises leadership in community healthcare and was this year presented to Kgomotso Kwenje and Dr Gilbert Khosa who co-manage the Bhubezi Community Health Centre in South Africa.

- Bhubezi Community Health Centre, located in Bushbuckridge, Mpumalanga, in South Africa, is the result of collaboration between the community, government and business. Supported by USAID / PEPFAR (the U.S. President's Emergency Plan for AIDS Relief), the South African Department of Health, Ndlovu Care Group, Anglo American and Virgin Unite, Bhubezi Community Health Centre is the first to offer basic and specialised healthcare in the region. Since its establishment in 2007 it has received more than 130,000 patients and provided more than 3,500 HIV positive patients with anti-retroviral treatment.

- Anglo American's recent progress was rewarded by the Global Business Coalition (GBC) on HIV/AIDS, Tuberculosis and Malaria at the organisation's Business Excellence Awards in June 2009, where the company's Thermal Coal business was recognised as having the best HIV/AIDS workplace programme in the world.

- The GBC Awards are earned by companies that have demonstrated extraordinary commitment, action and results, and have achieved exceptional success in putting their assets to work in the fight against HIV/AIDS, tuberculosis and malaria.

- Anglo American's Thermal Coal business received the top award in the 'Workplace Category' for its holistic approach to HIV/AIDS and was commended by the judges for "its comprehensive, robust and evidence-based approach to managing HIV and AIDS in the workplace; coupled with the outstanding leadership and commitment of the company's management and leadership team."

- Combating HIV/AIDS, Malaria and other diseases is one of the eight United Nations Millennium Development Goals (MDG) and 2010 represents an important milestone in the progress of this initiative.

About Anglo American

Anglo American plc is one of the world's largest mining companies, is headquartered in the UK and listed on the London and Johannesburg stock exchanges. Anglo American's portfolio of mining businesses spans precious metals and minerals - in which it is a global leader in both platinum and diamonds; base metals - copper and nickel; and bulk commodities - iron ore, metallurgical coal and thermal coal. Anglo American is committed to the highest standards of safety and responsibility across all its businesses and geographies and to making a sustainable difference in the development of the communities around its operations. The company's mining operations and extensive pipeline of growth projects are located in southern Africa, South America, Australia, North America and Asia. http://www.angloamerican.com

For further information on Anglo American, please contact:

    
    Media

    UK

    James Wyatt-Tilby
    Tel: +44(0)20-7968-8759

    Emily Blyth
    Tel: +44(0)20-7968-8481

    Investors

    UK 

    Caroline Metcalfe
    Tel: +44(0)20-7968-2192
 
    Leisha Wemyss
    Tel: +44(0)20-7968-8607

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.